Co-Director, Drug Policy Research Center
Rosalie Liccardo Pacula PhD is a Senior Economist at the RAND Corporation and a Professor at the Pardee RAND Graduate School. She serves as Director of RAND’s BING Center for Health Economics and is co-director of the RAND’s Drug Policy Research Center. Her research focuses on issues related to illegal or imperfect markets (health care markets, insurance markets, legal and illicit drug markets), the measurement of these markets, the impact they have on behavior, and the effectiveness of policy interventions at targeting behavior them. She was the lead investigator of several NIH studies examining the impact of marijuana liberalization policies (decriminalization, medicalization and legalization) on use and public health as well as their impact on the use of other substances (alcohol, prescription opioids and heroin). She has helped guide the scientific development of state-level policy databases, serving as an advisor to the Robert Wood Johnson Foundation’s Public Health Law Research Program and to the National Institute on Alcohol Abuse and Alcoholism’s APIS system. She was part of research teams providing guidance to Washington state, Vermont and Canada on their legalization initiatives, focusing on public health aspects of these laws. More recently her work has focused on assessing opioid markets, the drivers of the opioid epidemic, and the effectiveness of policies aimed at addressing it. Dr. Pacula is a member of the National Bureau of Economic Research (NBER) and a regular scientific reviewer for the National Institutes of Health, National Science Foundation, and a number of foundations and journals. She is the Vice President of the International Society for the Study of Drug Policy (ISSDP), and recently served on NIDA’s National Advisory Council on Drug Abuse Cannabis Policy Workgroup. She sits on several journal editorial boards and is an Assistant Editor for Addiction.
Thursday, October 11
5:00 PM – 5:30 PM